Publications by authors named "Benjamin D McElvany"

Claim this Profile
B
B cell receptor dependent enhancement of dengue virus infection.
Chad Gebo, Céline S C Hardy, Benjamin D McElvany, Nancy R Graham, Joseph Q Lu

PLoS Pathog· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters.
Camilla A Strother, Paul D Brewer-Jensen, Sylvia Becker-Dreps, Omar Zepeda, Samantha May, Benjamin D McElvany

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic.
Davis T Weaver, Benjamin D McElvany, Vishhvaan Gopalakrishnan, Kyle J Card, Dena Crozier

PLoS One· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
Stephen D Graham, Huy A Tu, Benjamin D McElvany, Nancy R Graham, Ariadna Grinyo

J Virol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity.
Nancy R Graham, Annalis N Whitaker, Camilla A Strother, Ashley K Miles, Dore Grier, Benjamin D McElvany

Clin Transl Immunology· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics and Isotype Assessment of Antibodies Targeting the Spike Protein Receptor Binding Domain of SARS-CoV-2 In COVID-19 Patients as a function of Age and Biological Sex.
Nancy R Graham, Annalis N Whitaker, Camilla A Strother, Ashley K Miles, Dore Grier, Benjamin D McElvany

medRxiv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human antibody response to Zika targets type-specific quaternary structure epitopes.
Matthew H Collins, Huy A Tu, Ciara Gimblet-Ochieng, Guei-Jiun Alice Liou, Ramesh S Jadi, Benjamin D McElvany

JCI Insight· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus.
Leah C Katzelnick, Ana Coello Escoto, Benjamin D McElvany, Christian Chávez, Henrik Salje

PLoS Negl Trop Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.
Stephen S Whitehead, Anna P Durbin, Kristen K Pierce, Dan Elwood, Benjamin D McElvany

PLoS Negl Trop Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.
Anna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, Marya P Carmolli, Cecilia M Tibery, Benjamin D McElvany

J Infect Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis